Cite
Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells.
MLA
Sheng, Q., et al. “Cisplatin‐mediated Down‐regulation of MiR‐145 Contributes to Up‐regulation of PD‐L1 via the C‐Myc Transcription Factor in Cisplatin‐resistant Ovarian Carcinoma Cells.” Clinical & Experimental Immunology, vol. 200, no. 1, Apr. 2020, pp. 45–52. EBSCOhost, https://doi.org/10.1111/cei.13406.
APA
Sheng, Q., Zhang, Y., Wang, Z., Ding, J., Song, Y., & Zhao, W. (2020). Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells. Clinical & Experimental Immunology, 200(1), 45–52. https://doi.org/10.1111/cei.13406
Chicago
Sheng, Q., Y. Zhang, Z. Wang, J. Ding, Y. Song, and W. Zhao. 2020. “Cisplatin‐mediated Down‐regulation of MiR‐145 Contributes to Up‐regulation of PD‐L1 via the C‐Myc Transcription Factor in Cisplatin‐resistant Ovarian Carcinoma Cells.” Clinical & Experimental Immunology 200 (1): 45–52. doi:10.1111/cei.13406.